Global ovarian cancer health disparities

Gynecologic Oncology

Volumn 129, Issue 1, 2013, Pages 258-264

  Chornokur, Ganna ^a,b   Amankwah, Ernest K ^a   Schildkraut, Joellen M ^c   Phelan, Catherine M ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Health disparities; Ovarian cancer; Race

Indexed keywords

CISPLATIN; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AFRICAN AMERICAN; CANCER GENETICS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COLON RESECTION; DEVELOPING COUNTRY; DISEASE FREE SURVIVAL; ETHNIC GROUP; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HEALTH DISPARITY; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; OVARY CANCER; PRIORITY JOURNAL; PRIVATE HEALTH INSURANCE; REVIEW; SOCIAL STATUS; TREATMENT OUTCOME; UNITED STATES;

AFRICAN AMERICANS; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 84875433896     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.12.016     Document Type: Review

References (73)

1. J. Ahmedin, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. C. Kosary Cancer of the ovary L.A.G. Ries, J.L. Young, G.E. Keel, M.P. Eisner, Y.D. Lin, SEER survival monograph: cancer survival among adults: US SEER program, 1988-2001, patient and tumor characteristics 2007 National Cancer Institute, SEER Program Bethesda (Maryland)
3. G. Parham, J.L. Phillips, M.L. Hicks, N. Andrews, W.B. Jones, and H.M. Shingleton The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women Cancer 80 4 1997 816 826
4. V. McGuire, C.A. Jesser, and A.S. Whittemore Survival among U.S. women with invasive epithelial ovarian cancer Gynecol Oncol 84 2002 399 403
5. J.K. Chan, M. Zhang, J.M. Hu, J.Y. Shin, K. Osann, and D.S. Kapp Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States J Surg Oncol 97 2008 103 107
6. V.L. Williams, H.G. Stockwell, M.S. Hoffman, and J.S. Barnholtz-Sloan Racial differences in treatment modalities among female residents of Florida diagnosed with epithelial ovarian cancer J Gynecol Surg 26 1 2010 15 22
7. R.D. Cress, C.D. O'Malley, G.S. Leiserowitz, and S.L. Campleman Patterns of chemotherapy use for women with ovarian cancer: a population-based study J Clin Oncol 21 8 2003 1530 1535
8. C.R. Morris, M.T. Sands, and L.H. Smith Ovarian cancer: predictors of early-stage diagnosis Cancer Causes Control 21 2010 1203 1211
9. P.G. Moorman, R.T. Palmieri, L. Akushevich, A. Berchuck, and J.M. Schildkraut Ovarian cancer risk factors in African-American and white women Am J Epidemiol 170 5 2009 598 606
10. J.S. Barnholtz-Sloan, M.A. Tainsky, J. Abrams, R.K. Severson, F. Qureshi, and S.M. Jacques Ethnic differences in survival among women with ovarian carcinoma Cancer 94 6 2002 1886 1893
11. R.M. Merrill, A.E. Anderson, and J.G. Merrill Racial/ethnic differences in the use of surgery for ovarian cancer in the United States Adv Med Sci 55 1 2010 93 98
12. X.L. Du, C.C. Sun, M.R. Milam, D.C. Bodurka, and S. Fang Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer Int J Gynecol Cancer 18 2008 660 669
13. J.D. Wright, T. Doan, R. McBride, J.S. Jacobson, and D.L. Hershman Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival Br J Cancer 98 2008 1197 1203
14. L.C. Harlan, L.X. Clegg, and E.L. Trimble Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States J Clin Oncol 21 18 2003 3488 3494
15. M. Terplan, E.J. Smith, and S.M. Temkin Race in ovarian cancer treatment and survival: a systematic review with meta-analysis Cancer Causes Control 20 2009 1139 1150
16. S. Kim, T.A. Dolecek, and F.G. Davis Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach Soc Sci Med 71 2010 274 281
17. O.W. Brawley Is race really a negative prognostic factor for cancer? JNCI 101 14 2009 970 971
18. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin, and GLOBOCAN Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet] 2010 International Agency for Research on Cancer Lyon, France [Available from: http://globocan.iarc.fr ]
19. M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics CA Cancer J Clin 55 2002 74 108
20. R.J. Kurman, K. Visvanathan, R. Roden, and Shih l.-M. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis Am J Obstet Gynecol 198 4 2008 351 356
21. D.L. Clarke-Pearson Screening for ovarian cancer N Engl J Med 361 2009 170 177
22. P.O. Brown, and C. Palmer The preclinical natural history of serous ovarian cancer: defining the target for early detection PLoS Med 6 7 2009 e1000114 10.1371/journal.pmed.1000114
23. R. Sankaranarayanan Worldwide burden of gynaecological cancer: the size of the problem Best Pract Res Clin Obstet Gynaecol 20 2 2006 207 225
24. M.F. Vine, B. Calingaert, A. Berchuck, and J.M. Schildkraut Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls Gynecol Oncol 90 1 2003 75 82
25. J.K. Bower, P.J. Schreiner, B. Sternfeld, and C.E. Lewis Black-White differences in hysterectomy prevalence: the CARDIA study Am J Public Health 99 2 2009 300 307
26. S.E. Hankinson, D.J. Hunter, G.A. Colditz, W.C. Willett, M.J. Stampfer, and B. Rosner Tubal ligation, hysterectomy, and risk of ovarian cancer JAMA 270 23 1993 2813 2818
27. J. Permuth-Wey, and T.A. Sellers Epidemiology of ovarian cancer M. Verma, Methods in molecular biology Cancer epidemiology 472 2009 413 438 10.1007/978-1-60327-492-0
28. M.J. Hall, J.E. Reid, L.A. Burbidge, D. Pruss, A.M. Deffenbaugh, and C. Frye BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer Cancer 115 10 2009 2222 2233
29. S. Karami, H.A. Young, and D.E. Henson Earlier age at diagnosis: another dimension in cancer disparity? Cancer Detect Prev 31 2007 29 34
30. M.S. Tetsche, M. Norgaard, J. Jacobsen, P. Wogelius, and H.T. Sorensen Comorbidity and ovarian cancer survival in Denmark, 1995-2005: a population-based cohort study Int J Gynecol Cancer 18 3 2008 421 427
31. M. Extermann Interaction between comorbidity and cancer Cancer Control 14 1 2007 13 22
32. E.A. Boyce, I. Costaggini, A. Vitonis, C. Feltmate, M. Muto, and R. Berkowitz The epidemiology of ovarian granulosa cell tumors: a case-control study Gynecol Oncol 115 2009 221 225
33. M.A. Morgan, K. Behbakht, I. Benjamin, M. Berlin, S.A. King, and S.C. Rubin Racial differences in survival from gynecologic cancer Obstet Gynecol 88 6 1996 914 918
34. E. Goss, A.M. Lopez, C.L. Brown, D.S. Wollins, O.W. Brawley, and D. Raghavan American Society of Clinical Oncology policy statement: disparities in cancer care J Clin Oncol 27 2009 2881 2885
35. J.S. Berek, and R.C. Bast Ovarian cancer D.W. Kufe, R.E. Pollock, R.R. Weichselbaum, R.C.J. Bast, T.S. Gansler, J.F. Holland, E. Frei, Cancer medicine 6 2003 BC Decker Inc. London
36. E.L. Goode, G. Chenevix-Trench, H. Song, S.J. Ramus, M. Notaridou, and K. Lawrenson A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 Nat Genet 42 2010 874 879
37. C.N. Landen, M.J. Birrer, and A.K. Sood Early events in the pathogenesis of epithelial ovarian cancer J Clin Oncol 26 6 2008 995 1005
38. J.M. Schildkraut, E.L. Goode, M.A. Clyde, E.S. Iversen, P.G. Moorman, and A. Berchuk Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer Cancer Res 69 2009 2349
39. A. Peedicayil, R.A. Vierkant, V. Shridhar, J.M. Schildkraut, S. Armasu, and L.C. Hartmann Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer Gynecol Oncol 114 2 2009 260 264
40. K.L. White, R.A. Vierkant, C.M. Phelan, B. Fridley, S. Anderson, and K. Knutson Polymorphisms in NF-κB inhibitors and risk of epithelial ovarian cancer BMC Cancer 9 2009 170
41. E.L. Goode, B.L. Fridley, R.A. Vierkant, J.M. Cunningham, C.M. Phelan, and S. Anderson Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk Cancer Epidemiol Biomarkers Prev 18 3 2009 935 944
42. E.L. Goode, M.J. Maurer, T.A. Sellers, C.M. Phelan, K.R. Kalli, and B.L. Fridley Inherited determinants of ovarian cancer survival Clin Cancer Res 16 3 2010 995 1007
43. A. Peedicayil, R.A. Vierkant, L.C. Hartmann, B.L. Fridley, Z.S. Fredericksen, and K.L. White Risk of ovarian cancer and inherited variants in relapse-associated genes PLoS One 5 1 2010 e8884 10.1371/journal.pone.0008884
44. M.C. King, J.H. Marks, and J.B. Mandell Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 5645 2003 643 646
45. K.M. Schmeler, H.T. Lynch, L.M. Chen, M.F. Munsell, P.T. Soliman, and M.B. Clark Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome N Engl J Med 354 2006 261 269
46. I. Harley, B. Rosen, H.A. Risch, K. Siminovitch, M.E. Beiner, and J. McLaughlin Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1 Gynecol Oncol 109 3 2008 384 387
47. H.D. Nelson, L.H. Huffman, R. Fu, and E.L. Harris Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force Ann Intern Med 143 5 2005 362 379
48. K. Armstrong, E. Micco, A. Carney, J. Stopfer, and M. Putt Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer JAMA 293 2005 1729 1736
49. J.A. Pagán, D. Su, L. Li, K. Armstrong, and D.A. Asch Racial and ethnic disparities in awareness of genetic testing for cancer risk Am J Prev Med 37 6 2009 524 530
50. W. Olaya, P. Esquivel, J.H. Wong, J.W. Morgan, A. Freeberg, and S. Roy-Chowdhury Disparities in BRCA testing: when insurance coverage is not a barrier Am J Surg 198 2009 562 565
51. J.M. Schildkraut, S.K. Murphy, R.T. Palmieri, E.S. Iversen, P.G. Moorman, and Z. Huang Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer Cancer Epidemiol Biomarkers Prev 16 2007 473
52. B.G. Haffty, A. Silber, E. Matloff, J. Chung, and D. Lannin Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women J Med Genet 43 2006 133 137
53. A.G. Zeimet, D. Reimer, N. Concin, S. Braun, and C. Marth Primary chemotherapy and maintenance therapy in epithelial ovarian cancer MEMO 1 2008 99 102
54. R. Angioli, F. Plotti, I. Palaia, M. Calcagno, R. Montera, and E.V. Cafà Update on lymphadenectomy in early and advanced ovarian cancer Curr Opin Obstet Gynecol 20 1 2008 34 39
55. H.S. Kim, W. Ju, B.C. Jee, Y.B. Kim, N.H. Park, and Y.S. Song Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysis Int J Gynecol Cancer 20 4 2010 520 528
56. L. Sterling, L. van Lonkhuijzen, J. Nyangena, E. Orango, M. Strother, and N. Busakhala Protocol development for ovarian cancer treatment in Kenya: a brief report Int J Gynecol Cancer 2 2 2011 424 427
57. D. Chase, S. Fedewa, T.S. Chou, A. Chen, E. Ward, and W.R. Brewster Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy? Obstet Gynecol 119 1 2012 68 77
58. J.S. Barnholtz-Sloan, A.G. Schwartz, F. Qureshi, S. Jacques, J. Malone, and A.R. Munkarah Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades Am J Obstet Gynecol 189 2003 1120 1127
59. B.A. Goff, B.J. Matthews, E.H. Larson, H.A. Andrilla, M. Wynn, and D.M. Lishner Predictors of comprehensive surgical treatment in patients with ovarian cancer Cancer 109 2007 2031 2042
60. J.K. Chan, E.G. Munro, M.K. Cheung, A. Husain, N.N. Teng, and J.S. Berek Association of lymphadenectomy and survival in stage I ovarian cancer patients Obstet Gynecol 109 2007 12 19
61. M.A. Aranda, M. McGory, E. Sekeris, M. Maggard, K. Ko, and D.S. Zingmond Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer? Gynecol Oncol 111 2008 166 172
62. R.E. Bristow, M.L. Zahurak, and O.A. Ibeanu Racial disparities in ovarian cancer surgical care: a population-based analysis Gynecol Oncol 121 2 2011 364 368
63. R.E. Bristow, B.E. Palis, D.S. Chi, and W.A. Cliby The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm Gynecol Oncol 118 3 2010 262 267
64. K.S. Albain, J.M. Unger, J.J. Crowley, C.A. Coltman Jr., and D.L. Hershman Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group J Natl Cancer Inst 101 2009 984 992
65. H.L. Howe, K.-H. Tung, S. Coughlin, R. Jean-Baptiste, and J. Hotes Race/ethnic variations in ovarian cancer mortality in the United States, 1992-1997 Cancer 97 Supplement (10) 2003 2686 2693
66. M. Terplan, N. Schluterman, E.J. McNamara, K. Tracy, and S.M. Temkin Have racial disparities in ovarian cancer increased over time? An analysis of SEER data Gynecol Oncol 125 1 2010 19 24
67. W.E. Winter III, G.L. Maxwell, C. Tian, J.W. Carlson, R.F. Ozols, and P.G. Rose Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study J Clin Oncol 25 2007 3621 3627
68. S.M. Temkin, E. Lengyel, A. Tergas, and M. Terplan Ovarian cancer treatment in black and white women: a comparison of clinicopathologic factors and outcome J Clin Oncol 26 15S 2008 16531
69. M. Terplan, S. Temkin, A. Tergas, and E. Lengyel Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer Gynecol Oncol 111 2 2008 173 178
70. J.H. Farley, C. Tian, G.S. Rose, C.L. Brown, M. Birrer, and G.L. Maxwell Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel Cancer 115 2009 4210 4217
71. Farley JH, Tian C, Rose GS, Brown CL, Risinger JI, Maxwell GL. Ethnicity and clinical outcome for advanced epithelial ovarian cancer patients treated by standard cisplatin/paclitaxel chemotherapy: a combined analysis of gynecologic oncology group clinical trials. J Clin Oncol 2008; ASCO Annual Meeting Proceedings 26(15S): 5573.
72. C.D. O'Malley, R.D. Cress, S.L. Campleman, and G.S. Leiserowitz Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study Gynecol Oncol 91 2003 608 615
73. R.E. Bristow, S. Ueda, M.A. Gerardi, O.B. Ajiboye, and O.A. Ibeanu Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center Gynecol Oncol 122 2 2011 319 323